Literature DB >> 15592673

[Undifferentiated pancreatic carcinomas. Leap into chaos].

K Peters1, G Klöppel.   

Abstract

Undifferentiated pancreatic carcinomas are rare anaplastic variants of ductal adenocarcinoma of the pancreas. They have to be distinguished immunohistochemically from metastases of malignant melanoma or an infiltrating sarcoma. An uncommon variant is undifferentiated pancreatic carcinoma with osteoclast-like giant cells. This variant can be associated with mucinous cystic neoplasms and is characterized by abundant non-neoplastic osteoclast-like giant cells.

Entities:  

Mesh：

Year:  2005        PMID： 15592673     DOI： 10.1007/s00292-004-0731-4

Source DB:  PubMed          Journal:  Pathologe        ISSN： 0172-8113            Impact factor:   1.011


  9 in total

1.  Reduced membranous and ectopic cytoplasmic expression of beta -catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer.

Authors:  Q Qiao; M Ramadani; S Gansauge; F Gansauge; G Leder; H G Beger
Journal:  Int J Cancer       Date:  2001-05-20       Impact factor: 7.396

2.  Phenotypical characteristics of undifferentiated carcinoma of the pancreas: a comparison with pancreatic ductal adenocarcinoma and relevance of E-cadherin, alpha catenin and beta catenin expression.

Authors:  H Yonemasu; M Takashima; K I Nishiyama; T Ueki; T Yao; M Tanaka; M Tsuneyoshi
Journal:  Oncol Rep       Date:  2001 Jul-Aug       Impact factor: 3.906

3.  Giant cell tumor of the pancreas of the osteoclastic type associated with a mucous secreting cystadenocarcinoma.

Authors:  J A Posen
Journal:  Hum Pathol       Date:  1981-10       Impact factor: 3.466

Review 4.  Mucinous cystic neoplasms of the pancreas.

Authors:  R E Wilentz; J Albores-Saavedra; R H Hruban
Journal:  Semin Diagn Pathol       Date:  2000-02       Impact factor: 3.464

5.  Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin.

Authors:  A Hoorens; K Prenzel; N R Lemoine; G Klöppel
Journal:  J Pathol       Date:  1998-05       Impact factor: 7.996

Review 6.  Osteoclastic giant cell tumor of the pancreas. An immunohistological study and review of the literature.

Authors:  O Dworak; C Wittekind; H P Koerfgen; F P Gall
Journal:  Pathol Res Pract       Date:  1993-03       Impact factor: 3.250

7.  Osteoclast-type giant cell tumor of the pancreas associated with mucinous cystadenoma.

Authors:  A Menteş; G Yüce
Journal:  Eur J Surg Oncol       Date:  1993-02       Impact factor: 4.424

Review 8.  K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: genetic evidence to support origin from the duct epithelium.

Authors:  W H Westra; P Sturm; P Drillenburg; M A Choti; D S Klimstra; J Albores-Saavedra; A Montag; G J Offerhaus; R H Hruban
Journal:  Am J Surg Pathol       Date:  1998-10       Impact factor: 6.394

9.  Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage.

Authors:  M Pignatelli; T W Ansari; P Gunter; D Liu; S Hirano; M Takeichi; G Klöppel; N R Lemoine
Journal:  J Pathol       Date:  1994-12       Impact factor: 7.996
  9 in total
  2 in total

1.  Metastasis to the pancreas--an indication for pancreatic resection?

Authors:  S Eidt; M Jergas; R Schmidt; M Siedek
Journal:  Langenbecks Arch Surg       Date:  2007-01-23       Impact factor: 3.445

2.  Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer.

Authors:  Jordan M Winter; Angela H Ting; Felip Vilardell; Eike Gallmeier; Steve B Baylin; Ralph H Hruban; Scott E Kern; Christine A Iacobuzio-Donahue
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.